ABBV · AbbVie Inc.
AbbVie Inc. ABBV
Develops and markets prescription medicines and therapies, including treatments for immunology, oncology, and neuroscience as well as Botox-brand aesthetics.
- Industry
- Biotechnology
- Listed on
- New York Stock Exchange
- IPO
- 2013-01-02
- Website
- abbvie.com
No coverage yet. Updates appear here when AbbVie Inc. is in the news.
More on AbbVie Inc.
Earnings
- Q3 2026 earnings · October 30, 2026
This content is for informational purposes only and is not investment advice. Always do your own research before making financial decisions.